Phased ACN entry at $180 with $158 hard stop; scale to full on $170-172 pullback, target $215-235
Buy rating grounded in three factors: (1) Fundamental bull case outweighs bear—12.27x forward P/E vs 18-22x historical, 24% ROE, $10.87B FCF inflection (+26% YoY), $3.30B net cash, and live AI integrator wins decisively overpower tactical concerns; (2) Prior Hold decisions produced -0.1% alpha while sitting in cash failed three times on this ticker, validating trim-to-redeploy rather than indefinite carry; (3) Phased deployment respects technical concerns (RSI 70.64 overbought, 200 SMA 12% overhead) without surrendering the asymmetric value gap. Buy rather than Overweight due to macro warnings (no-cut Fed, strong dollar on 50%+ non-USD revenue, working capital deterioration, goodwill at 36% of assets) warrant sizing discipline—40-50% initial position threads the conservative-conservative line for a $110B market-cap, AA credit, 3.6% dividend compounder at a genuine valuation discount.
| Position | Action |
|---|---|
| Initial position: 40-50% of target weight | ENTER |
| Pullback to $170-172 (10 EMA zone) | SCALE TO FULL |
| Cap at 50% of full weight into late September FY26 Q4 earnings | HOLD AT 50% |
| Price reaches $195 | TRIM 25% |
| Price reaches $215 | TRIM 25% |
| Price trails below 10 EMA | TRAIL REMAINDER |
Accenture is a best-in-class compounder at half its historical valuation multiple, in the early innings of a sentiment reversal, with a fortress balance sheet, inflecting FCF profile, 3.6% yield, and visible AI-services deal flow.
| Indicator | Value | Signal |
|---|---|---|
| Price | $180.14 | neutral |
| 10 EMA | $172.08 | bullish |
| 50 SMA | $152.28 | bullish |
| 200 SMA | $204.86 | bearish |
| RSI (14) | 70.64 | bearish |
| MACD | +8.86 | bullish |
| MACD Signal | +6.55 | bullish |
| MACD Histogram | +2.30 (declining from 4.58) | bearish |
| Bollinger Upper Band | $190.20 | bearish |
| Bollinger Middle Band (20 SMA) | $160.63 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Pullback to $170-172 (10 EMA zone)
Then: SCALE TO FULL POSITION
FY2025 revenue reaccelerated to +7.4% with FCF inflecting +26% YoY, demonstrating a company accelerating cash generation
↩ rebuts: “Bear claim of soft FY26 revenue and weak bookings being a deal-breaker”
EV: $265-$322 · concedes: The 200 SMA at $204.86 is legitimate overhead resistance, though framed as a target rather than a ceiling; RSI at 70.64 is genuinely overbought in the short term; The rally has already happened and chasing is a valid tactical concern; Possible multiple compression to 14-16x is acknowledged as possible; Geopolitical headwinds and dollar-strength are real but priced in; FY26 commentary was cautious, though seen as one-quarter noise
Accenture is a textbook momentum chase into a structural value trap at $180 — overbought technicals, FCF inflation from working capital release and debt issuance rather than organic strength, management's own cautious bookings guidance contradicted by press-release deal announcements, goodwill-loaded balance sheet with rising leverage, and sector-wide demand softening signals from peers all argue for waiting for a pullback to $152-$160 before establishing positions.
EV: -11% to -20% (to $160 and $152 respectively) · concedes: ACN is a high-quality business; Balance sheet is not broken; Cash flow is real; Some AI deals may eventually contribute; Patient capital can be rewarded if waiting for pullback
→ vs conservative: Waiting for 200 SMA confirmation at $204.86 means buying at full price what can be purchased today at $180 — a 14% worse entry on a mean reversion thesis
→ vs conservative: The 'overbought RSI' critique is lazy analysis; RSI staying elevated for weeks after capitulation rallies is the signature of powerful trend reversions, not topping patterns
→ vs conservative: The 'wait for pullback to 50-day MA at $153' approach creates perpetual inaction as new reasons to avoid buying will always emerge
→ vs conservative: The 200 SMA at $204.86 is a lagging indicator anchored to data from months ago when ACN traded above $250 — it no longer reflects company reality
→ vs neutral: The 'unresolved AI disruption narrative' has already been resolved by data: FY25 reacceleration, deal pipeline, and Fortune 500 client contracts disprove the threat thesis in real time
→ vs conservative: MACD histogram compression after vertical moves is normal profit-taking behavior; the conservative is reading a topping pattern where there is only digestion
| Bollinger Lower Band |
| $131.07 |
| neutral |
| ATR (14) | $7.88 | neutral |
| VWMA | $165.74 | bullish |
Support: 172.08 · 160.63 · 152.28 | Resistance: 190.2 · 204.86
ACN staged a powerful reversal from $129.57 in late June to $180.14 by August 12 (+39% in 6 weeks), with price above both the 10 EMA ($172.08) and 50 SMA ($152.28) indicating a strong short-term uptrend. However, the 200 SMA at $204.86 remains above current price, confirming the long-term trend has not been reclaimed. Key warning signs include overbought RSI (70.64), a declining MACD histogram (2.30 vs. 4.58 peak on Jul 29) suggesting momentum divergence, and price near the upper Bollinger Band at $190.20. ATR of $7.88 (4.4% of price) indicates elevated volatility requiring wider stop-loss placement. Rising volume confirms the rally, and VWMA at $165.74 validates accumulation. Recommended action is a cautious HOLD for trend-followers with tight trailing stops below the 10 EMA; pullback entries toward $172 offer better risk/reward for new positions.
Market Cap
$110.24B
P/E (TTM)
14.39x
Forward P/E
12.27x
PEG Ratio
1.30
P/B
3.46x
Dividend Yield
3.63%
Beta
1.07
52-Week High
$291.09
52-Week Low
$118.15
50-Day MA
$153.50
200-Day MA
$208.59
TTM EPS
$12.52
Forward EPS
$14.68
Implied Current Price
~$180
Gross Margin (TTM)
32.0%
Operating Margin (TTM)
16.96%
Net Margin (TTM)
10.66%
ROE
24.41%
ROA
10.90%
EBITDA Margin (TTM)
17.7%
Revenue (TTM)
$73.10B
Revenue (FY2025)
$69.67B
Revenue (FY2024)
$64.90B
Revenue (FY2023)
$64.11B
Revenue (FY2022)
$61.59B
Revenue (FY2021)
~$50.53B
Revenue Growth FY24→FY25
+7.4%
Net Income Growth FY24→FY25
+5.7%
EPS Growth FY24→FY25
+6.2%
Forward EPS Growth (TTM→Fwd)
+17.3%
Gross Profit (FY2025)
$22.24B
Operating Income (FY2025)
$10.84B
Net Income (FY2025)
$7.68B
Diluted EPS (FY2025)
$12.15
Cash (FY2025)
$11.48B
Total Debt (FY2025)
$8.18B
Net Cash (FY2025)
$3.30B
Total Equity (FY2025)
$31.20B
Current Ratio (FY2025)
1.34
Working Capital (FY2025)
$8.55B
Goodwill (FY2025)
$22.54B
Goodwill / Assets
34.5%
Total Assets (FY2025)
$65.39B
Equity / Assets
47.7%
Receivables Growth (FY24→FY25)
+10.1%
Tax Rate
~23.7%
Operating CF (FY2025)
$11.47B
Free Cash Flow (FY2025)
$10.87B
FCF Margin (FY2025)
15.6%
CapEx (FY2025)
$0.60B
CapEx Intensity
0.86%
Dividends Paid (FY2025)
$3.70B
Buybacks (FY2025)
$4.62B
Total Capital Returned (FY2025)
$8.32B
Capital Returned as % of FCF
76.5%
Acquisitions (FY2025)
$1.47B
Net Debt Issuance (FY2025)
+$4.13B
Long-Term Debt Issued (FY2025)
$5.06B
Buyback Intensity
~4.3%
Cash Doubled (FY24→FY25)
$5.00B → $11.48B
Stock Drawdown from High
~38%
Strengths
Concerns
Accenture is a high-quality compounder with exceptional fundamentals: 24.4% ROE, 15.6% FCF margin, and a net cash position of $3.3B. Revenue reaccelerated to 7.4% in FY2025 (+5% TTM into FY26), suggesting Gen-AI is a tailwind rather than a threat. The stock trades at a 38% discount to its 52-week high and at a 12.27x forward P/E—well below its historical 18-22x multiple—offering meaningful margin of safety. However, $22.5B in goodwill (36% of assets), debt doubling in two years, and unresolved Gen-AI disruption fears warrant a cautious HOLD posture.bulls should wait for either a break above the 200-day MA ($208.59) or a pullback to the 50-day MA ($153.50) for better entry.
Macro: Fed policy: 86% probability of zero rate cuts in 2026 (up from 83.6% prior), representing a hawkish hold consensus. US recession odds at 8% by end-2026 (down 1pp WoW), pricing in a soft landing. Lower-than-expected inflation print drove equity rally; disinflation environment provides mild tailwind. Nasdaq higher on inflation data, CoreWeave soaring confirms AI-infrastructure capex cycle intact. No imminent demand cliff for IT consulting in the US given low recession odds.